Alessia Villani (A Villani)

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 70

Top Topics

Basal Cell Carcinoma

Top Venues

Dermatologic therapy

Clinical and experimental dermatology

Journal of cosmetic dermatology

Journal of the European Academy of Dermatology and Venereology : JEADV

This page only lists publications with an associated author ORCID identifier.

Publications

Fabrizio Martora, Matteo Megna, Teresa Battista, Massimiliano Scalvenzi, Alessia Villani, Sara Cacciapuoti, Luca Potestio
Viral reactivation following COVID-19 vaccination: a review of the current literature. Clinical and experimental dermatology 49 (6) (2024)
Luca Potestio, Matteo Megna, Sara Cacciapuoti, Fabrizio Martora, Alessia Villani
Author Reply to "Comment on ChatGPT and Medical Writing in Dermatology: why should we keep writing?" by Duff et al. Clinical and experimental dermatology (2024)
Luca Potestio, Matteo Megna, Sara Cacciapuoti, Fabrizio Martora, Alessia Villani
Author Reply to "Comment on ChatGPT and Medical Writing in Dermatology: why should we keep writing?" by Daungsupawong et al. Clinical and experimental dermatology (2024)
Luca Potestio, Matteo Megna, Sara Cacciapuoti, Fabrizio Martora, Alessia Villani
ChatGPT and Medical Writing in Dermatology: why should we keep writing? Clinical and experimental dermatology (2024)
Luca Potestio, Matteo Megna, Sara Cacciapuoti, Fabrizio Martora, Alessia Villani
ChatGPT and medical writing in dermatology: why should we keep writing? Clinical and experimental dermatology 49 (8) (2024)
Fabrizio Martora, Matteo Megna, Teresa Battista, Massimiliano Scalvenzi, Alessia Villani, Sara Cacciapuoti, Luca Potestio
Viral Reactivation Following COVID-19 Vaccination: a review of the current literature. Clinical and experimental dermatology (2024)
Luca Potestio, Fabrizio Martora, Alessia Villani, Ruggiero Angelo, Massimiliano Scalvenzi, Matteo Megna
ChatGPT and Dermatology: friends or foes? Clinical and experimental dermatology (2023)
Luca Potestio, Fabrizio Martora, Alessia Villani, Sara Cacciapuoti, Teresa Battista, Matteo Megna
Advancing Dermatology: Embracing the Power of Artificial Intelligence. Clinical and experimental dermatology (2023)
Luca Potestio, Fabrizio Martora, Matteo Megna, Alessia Villani, Sara Cacciapuoti
Comment on 'Development of Chilblains Lesions During the COVID-19 Pandemic is Strongly Associated with Cold Weather: Retrospective Analysis of Patients from a Single Center in the United States'. Clinical and experimental dermatology (2023)
Luca Potestio, Alessia Villani, Flavia Raia, Gabriella Fabbrocini, Fabrizio Martora
Letter to the editor regarding article "Falotico JM, Gu L, Lipner SR. Not just pimple popping: The utility of hybrid telemedicine models beyond acne management amidst the ongoing COVID-19 pandemic. J Cosmet Dermatol. 2022;10.1111/jocd.15256". Journal of cosmetic dermatology 22 (3) (2023)
Luca Potestio, Fabrizio Martora, Alessia Villani, Matteo Megna, Ruggiero Angelo
Comment on: "Clinical characteristics of patients with pityriasis rubra pilaris following SARS-CoV-2 vaccination" by Gambichler. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Luca Potestio, Alessia Villani, Flavia Raia, Gabriella Fabbrocini, Fabrizio Martora
Letter to the editor regarding article "Falotico JM, Gu L, Lipner SR. Not just pimple popping: The utility of hybrid telemedicine models beyond acne management amidst the ongoing COVID-19 pandemic. J Cosmet Dermatol. 2022;10.1111/jocd.15256". Journal of cosmetic dermatology 22 (3) (2023)
Luca Potestio, Alessia Villani, Flavia Raia, Gabriella Fabbrocini, Fabrizio Martora
Letter to the editor regarding article "Falotico JM, Gu L, Lipner SR. Not just pimple popping: The utility of hybrid telemedicine models beyond acne management amidst the ongoing COVID-19 pandemic. J Cosmet Dermatol. 2022;10.1111/jocd.15256". Journal of cosmetic dermatology (2023)
Fabrizio Martora, Alessia Villani, Claudio Marasca, Gabriella Fabbrocini, Ruggiero Angelo
Cutaneous adverse reaction following COVID-19 vaccination: Report from a southern Italian referral centre. Comment on "cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine" by Luo et al. The Australasian journal of dermatology (2023)
Fabrizio Martora, Alessia Villani, Claudio Marasca, Gabriella Fabbrocini, Ruggiero Angelo
Cutaneous adverse reaction following COVID-19 vaccination: Report from a southern Italian referral centre. Comment on "cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine" by Luo et al. The Australasian journal of dermatology 64 (1) (2023)
Fabrizio Martora, Alessia Villani, Claudio Marasca, Gabriella Fabbrocini, Ruggiero Angelo
Cutaneous adverse reaction following COVID-19 vaccination: Report from a southern Italian referral centre. Comment on "cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine" by Luo et al. The Australasian journal of dermatology 64 (1) (2023)
Alessia Villani, Gabriella Fabbrocini, Giuseppe Micali, Luigi Fornaro, Luca Potestio, Massimiliano Scalvenzi
The Efficacy of Sonidegib in Treating Locally Advanced Basal Cell Carcinoma Involving the Periocular Area. Dermatology and therapy (2023)
Fabrizio Martora, Alessia Villani, Claudio Marasca, Gabriella Fabbrocini, Ruggiero Angelo
Cutaneous adverse reaction following COVID-19 vaccination: Report from a southern Italian referral centre. Comment on "cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine" by Luo et al. The Australasian journal of dermatology 64 (1) (2023)
Ruggiero Angelo, Fabrizio Martora, Luigi Fornaro, Gianluca Guerrasio, Francesca di Vico, Gabriella Fabbrocini, Massimiliano Scalvenzi, Alessia Villani
The impact of COVID-19 pandemic on nonmelanoma skin cancers: report of a Southern Italy referral centre. Clinical and experimental dermatology 47 (11) (2022)
Orlando Zagaria, Alessia Villani, Ruggiero Angelo, Luca Potestio, Gabriella Fabbrocini, Lucia Gallo
New-onset lichen planus arising after COVID-19 vaccination. Dermatologic therapy 35 (5) (2022)
Luca Potestio, Alessia Villani, Gabriella Fabbrocini, Fabrizio Martora
Cutaneous reactions following booster dose of COVID-19 mRNA vaccination: What we should know? Journal of cosmetic dermatology (2022)
Matteo Megna, Elisa Camela, Alessia Villani, Andrea Tajani, Gabriella Fabbrocini, Luca Potestio
Teledermatology: A useful tool also after COVID-19 era? Journal of cosmetic dermatology 21 (6) (2022)
Ruggiero Angelo, Claudio Marasca, Alessia Villani, Gabriella Fabbrocini, Fabrizio Martora
Tacrolimus ointment may improve the effectiveness of adalimumab in patients with hidradenitis suppurativa: a novel promising treatment. Clinical and experimental dermatology 47 (10) (2022)
Fabrizio Martora, Ruggiero Angelo, Gabriella Fabbrocini, Alessia Villani
Patient satisfaction with remote dermatology consultations during the COVID-19 pandemic. Comment on 'A qualitative assessment of patient satisfaction with remote dermatology consultations used during the UK's first wave of the COVID-19 pandemic in a single, secondary-care dermatology department'. Clinical and experimental dermatology 47 (11) (2022)
Alessia Villani, G Fabbrocini, Maria Carmela Annunziata, Luca Potestio
Maskne prevalence and risk factors during the COVID-19 pandemic. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (9) (2022)
Ruggiero Angelo, Claudio Marasca, Gabriella Fabbrocini, Alessia Villani, Fabrizio Martora
Teledermatology in the management of hidradenitis suppurativa: Should we improve this service? Journal of cosmetic dermatology (2022)
Fabrizio Martora, Alessia Villani, Teresa Battista, Gabriella Fabbrocini, Luca Potestio
COVID-19 vaccination and inflammatory skin diseases. Journal of cosmetic dermatology (2022)
Alessia Villani, Maria Carmela Annunziata, Matteo Megna, Massimiliano Scalvenzi, Gabriella Fabbrocini
Long-term results of teledermatology for acne patients during COVID-19 pandemic. Journal of cosmetic dermatology 21 (4) (2022)
Alessia Villani, Gabriella Fabbrocini, Tiziana Peduto, Massimiliano Scalvenzi
Reflectance confocal microscopy for Kaposi's sarcoma treatment monitoring after intralesional vincristine chemotherapy. Dermatologic therapy 35 (7) (2022)
Alessia Villani, Gabriella Fabbrocini, Claudia Costa, Luca Potestio, Massimiliano Scalvenzi
Sonidegib with and Without Adjunctive Treatment for Locally Advanced Basal Cell Carcinomas. The oncologist 27 (6) (2022)
Alessia Villani, Gabriella Fabbrocini, Massimiliano Scalvenzi
Sonidegib-induced muscle spasms in the treatment of basal cell carcinoma: Strategies to adopt. Dermatologic therapy 35 (7) (2022)
Elisa Camela, Alessia Villani, Massimiliano Scalvenzi, Claudia Costa
Giant basal cell carcinoma of the vulva successfully treated with Sonidegib. Dermatologic therapy 35 (9) (2022)
Fabrizio Martora, Alessia Villani, Gabriella Fabbrocini, Teresa Battista
COVID-19 and cutaneous manifestations: A review of the published literature. Journal of cosmetic dermatology (2022)
Alessia Villani, Massimiliano Scalvenzi, Gabriella Fabbrocini, Luigi Fornaro, Gianluca Guerrasio, Luca Potestio
Effects of COVID-19 pandemic on malignant melanoma diagnosis. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Luca Potestio, Alessia Villani, Gabriella Fabbrocini, Fabrizio Martora
Letter to the editor regarding article "Hlaca N, Zagar T, Kastelan M, Peternel S, Brajac I, Prpic-Massari L. New-onset lichen planus and lichen planus flare in elderly women after COVID-19 vaccination. J Cosmet Dermatol. 2022;10.1111/jocd.15185". Journal of cosmetic dermatology (2022)
Luca Potestio, Gabriella Fabbrocini, Alessia Villani
Letter to the editor regarding article "Gu L, Diaz SM, Lipner SR. Retrospective study of acne telemedicine and in-person visits at an academic center during the COVID-19 pandemic. J Cosmet Dermatol. 2022;21(1):36-38." Journal of cosmetic dermatology (2022)
Fabrizio Martora, Alessia Villani, Claudio Marasca, Gabriella Fabbrocini, Luca Potestio
Skin reaction after SARS-CoV-2 vaccines Reply to 'cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: A real-life multicentre experience'. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Alessia Villani, Luca Potestio, Gabriella Fabbrocini, Francesca di Vico, Claudia Costa, Massimiliano Scalvenzi
Long-term efficacy of telemedicine for patients with locally advanced basal cell carcinoma during COVID-19 pandemic. Dermatologic therapy 35 (11) (2022)
Luca Potestio, Lucia Genco, Alessia Villani, Claudio Marasca, G Fabbrocini, L Fornaro, Ruggiero Angelo, Fabrizio Martora
Reply to 'Cutaneous adverse effects of the available COVID-19 vaccines in India: A questionnaire-based study' by Bawane J et al. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (11) (2022)
Matteo Megna, Alessia Villani, Luca Potestio, Elisa Camela, Gabriella Fabbrocini, Sonia Sofia Ocampo-Garza
Adalimumab biosimilar in a pediatric patient: Clinical and in vivo reflectance confocal microscopy evaluation. Dermatologic therapy 35 (9) (2022)
Sonia Sofia Ocampo-Garza, Alessia Villani, Eleonora Cinelli, Elisa Camela, Gabriella Fabbrocini, Matteo Megna
Ixekizumab in scalp psoriasis: Clinical, dermoscopical, and in vivo reflectance confocal microscopy evaluation. Dermatologic therapy 35 (4) (2022)
Alessia Villani, Gabriella Fabbrocini, Massimiliano Scalvenzi
Sonidegib treatment in patients with locally advanced basal cell carcinoma. Dermatologic therapy 35 (4) (2022)
Ruggiero Angelo, Fabrizio Martora, Fabrizio Fornaro, Massimiliano Scalvenzi, Gabriella Fabbrocini, Alessia Villani
Reply to 'Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity' by R. Molinier et al. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Alessia Villani, Claudia Costa, Gabriella Fabbrocini, Massimiliano Scalvenzi
Systemic hedgehog inhibitors to treat locally advanced basal cell carcinomas of the head-neck region: A retrospective study. Dermatologic therapy 34 (5) (2021)
Alessia Villani, Massimiliano Scalvenzi, Gabriella Fabbrocini, Jorge Ocampo-Candiani, Sonia Sofía Ocampo-Garza
Looking into a Better Future: Novel Therapies for Metastatic Melanoma. Dermatology and therapy 11 (3) (2021)
Alessia Villani, M Scalvenzi, T Peduto, Eleonora Cinelli, G Fabbrocini, Alessandro Di Stefani
Dermoscopy and reflectance confocal microscopy of Kaposi's sarcoma: an overview. Journal of the European Academy of Dermatology and Venereology : JEADV (2021)
Alessia Villani, G Fabbrocini, Jorge Ocampo Candiani, Ruggiero Angelo, Sonia Sofia Ocampo-Garza
Review of oral minoxidil as treatment of hair disorders: in search of the perfect dose. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (7) (2021)
Sonia Sofia Ocampo-Garza, Jorge Ocampo Candiani, E Camela, Marina Vastarella, G Fabbrocini, M Scalvenzi, Alessia Villani
Nail changes as manifestation of systemic disease in COVID-19 infection. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (8) (2021)
Alessia Villani, Gabriella Fabbrocini, Claudia Costa, Massimiliano Scalvenzi
Vismodegib treatment in advanced basal cell carcinomas: Real-life experience. Dermatologic therapy (2021)
Elisa Camela, Sonia Sofia Ocampo-Garza, Eleonora Cinelli, Alessia Villani, Gabriella Fabbrocini, Matteo Megna
Therapeutic update of biologics and small molecules for scalp psoriasis: a systematic review. Dermatologic therapy 34 (2) (2021)
Alessia Villani, Gabriella Fabbrocini, Claudia Costa, Massimiliano Scalvenzi
Reflectance Confocal Microscopy Identification of Subclinical Basal Cell Carcinoma after Vismodegib Treatment: Report of a Case. Dermatology and therapy 11 (3) (2021)
Alessia Villani, Gabriella Fabbrocini, Claudia Costa, Massimiliano Scalvenzi
Awareness on sun protection behavior among melanoma and nonmelanoma skin cancer patients: An Italian tertiary cancer center experience. Dermatologic therapy 34 (2) (2021)
Alessia Villani, Claudia Costa, Gabriella Fabbrocini, Massimiliano Scalvenzi
Drug holiday regimen for vismodegib treatment in patients with multiple primary basal cell carcinomas. Dermatologic therapy 33 (4) (2020)
Alessia Villani, Gabriella Fabbrocini, Claudia Costa, Massimiliano Scalvenzi
Complete remission of an advanced basal cell carcinoma after only 3-month treatment with sonidegib: Report of a case and drug management during COVID-19 pandemic. Dermatologic therapy 33 (6) (2020)
Vincenzo Greco, Milena Cappello, Matteo Megna, Claudia Costa, Alessia Villani, Gabriella Fabbrocini, Vincenzo Marino, Massimiliano Scalvenzi
Dermoscopic patterns of intradermal naevi. The Australasian journal of dermatology 61 (4) (2020)
Ruggiero Angelo, Claudio Marasca, Sonia Sofia Ocampo-Garza, Gabriella Fabbrocini, Alessia Villani
SMS support group in the management of acne: A useful tool to increase adherence to treatment. Dermatologic therapy 34 (1) (2020)
Alessia Villani, Maria Carmela Annunziata, Maria Antonietta Luciano, Gabriella Fabbrocini
Skin needling for the treatment of acne scarring: A comprehensive review. Journal of cosmetic dermatology 19 (9) (2020)
Claudio Marasca, Ruggiero Angelo, G Fontanella, Maria Ferrillo, G Fabbrocini, Alessia Villani
Telemedicine and support groups could be used to improve adherence to treatment and health-related quality of life in patients affected by inflammatory skin conditions during the COVID-19 pandemic. Clinical and experimental dermatology 45 (6) (2020)
Ruggiero Angelo, Matteo Megna, Maria Carmela Annunziata, L Abategiovanni, M Scalvenzi, A Tajani, G Fabbrocini, Alessia Villani
Teledermatology for acne during COVID-19: high patients' satisfaction in spite of the emergency. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (11) (2020)
Alessia Villani, M Cappello, C Costa, G Fabbrocini, M Scalvenzi
Advanced basal cell carcinoma treated with vismodegib: impact on the lives of patients and their families. Clinical and experimental dermatology 45 (8) (2020)
Alessia Villani, Maria Carmela Annunziata, Luisa Abategiovanni, Gabriella Fabbrocini
Teledermatology for acne patients: How to reduce face-to-face visits during COVID-19 pandemic. Journal of cosmetic dermatology 19 (8) (2020)
Gaia De Fata Salvatores, Alessia Villani, Gabriella Fabbrocini, Adriana Di Guida
Patients with bullous disorders during COVID-19 period: Management and adherence to treatment. Dermatologic therapy 33 (6) (2020)
Maria Ferrillo, Cataldo Patruno, Alessia Villani, M Scalvenzi, Gabriella Fabbrocini, M D'Andrea, Maddalena Napolitano
Dermoscopic assessment of long-term systemic therapy with dupilumab in adult atopic dermatitis. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (11) (2020)
Sonia Sofia Ocampo-Garza, Gabriella Fabbrocini, Jorge Ocampo Candiani, Eleonora Cinelli, Alessia Villani
Micro needling: A novel therapeutic approach for androgenetic alopecia, A Review of Literature. Dermatologic therapy 33 (6) (2020)
Alessia Villani, Matteo Megna, Massimiliano Scalvenzi, Gabriella Fabbrocini, Ruggiero Angelo
Teledermatology and chronic skin diseases: Real life experience in a Southern Italian Dermatologic Centre. Dermatologic therapy 33 (6) (2020)
Alessia Villani, Gabriella Fabbrocini, Claudia Costa, Milena Cappello, Massimiliano Scalvenzi
Assessment of the adverse events related to hedgehog pathway inhibitor therapy for basal cell carcinoma: A single-centre retrospective study. The Australasian journal of dermatology 62 (2) (2020)
Alessia Villani, G Fabbrocini, C Costa, Vincenzo Greco, M Scalvenzi
Second primary melanoma: incidence rate and risk factors. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (10) (2020)
Matteo Megna, A Pecoraro, N Balato, Alessia Villani, L Crescenzi, Anna Balato, G Spadaro
Psoriasis in a cohort of patients with common variable immunodeficiency. The British journal of dermatology 180 (4) (2019)
Massimiliano Scalvenzi, Matteo Megna, Claudia Costa, Gabriella Fabbrocini, Alessia Villani, Vincenzo Greco
Cutaneous melanoma associated with naevi prevalence: A 15-year cross-sectional retrospective study. The Australasian journal of dermatology 61 (1) (2019)
M Scalvenzi, C Costa, G De Fata Salvatores, M Cappello, Alessia Villani
Clinical and dermoscopic features of Spitz naevus by sex, age and anatomical site: a study of 913 Spitz naevi. The British journal of dermatology 179 (3) (2018)